Abstract | INTRODUCTION: METHODS: A retrospective examination was made of the demographic characteristics and the follicular-embryonic development results of PCOS patients applied with an antagonist protocol of ovarian hyperstimulation in the first cycle of IVF with co-treatment of Metformin at 2000 mg/day regularly for 3 months ( Metformin co-treatment group, n:35) or Inositol at 4000 mg/day myo- inositol for 3 months ( Inositol co-treatment group, n:34) and those not using any co-treatment (FSH only group [control group], n:40). RESULTS: No significant difference was determined between the groups in respect of demographic characteristics. The HOMA-IR scores and hCG day E2 level were significantly higher in the control group than in both co-treatment groups (p = 0.021, p = 0.018, respectively). The M1 oocyte count was significantly lower in the Metformin group than in the Inositol and control groups (p = 0.001). The GVDJ oocyte count was significantly lower in both co-treatment groups than in the control group (p = 0.042). No statistically significant difference was determined between the groups in respect of other follicular and embryological development parameters, implantation, clinical pregnancy, live births and abortus rates. CONCLUSION:
Insulin-sensitizing agents may have positive effects on follicular development in PCOS patients applied with IVF.
|
Authors | Aslı Yaylalı, Murat Bakacak, Zeyneb Bakacak |
Journal | Journal of gynecology obstetrics and human reproduction
(J Gynecol Obstet Hum Reprod)
Vol. 50
Issue 1
Pg. 102006
(Jan 2021)
ISSN: 2468-7847 [Electronic] France |
PMID | 33242676
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2020 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Chorionic Gonadotropin
- Hypoglycemic Agents
- Vitamin B Complex
- Inositol
- Metformin
|
Topics |
- Adult
- Case-Control Studies
- Cell Count
- Chorionic Gonadotropin
(blood)
- Female
- Fertilization in Vitro
- Humans
- Hypoglycemic Agents
(therapeutic use)
- Inositol
(therapeutic use)
- Metformin
(therapeutic use)
- Oocytes
- Polycystic Ovary Syndrome
(drug therapy)
- Retrospective Studies
- Vitamin B Complex
(therapeutic use)
- Young Adult
|